{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T17:15:17Z","timestamp":1763399717459},"reference-count":42,"publisher":"Tohoku University Medical Press","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2017]]},"DOI":"10.1620\/tjem.241.255","type":"journal-article","created":{"date-parts":[[2017,3,31]],"date-time":"2017-03-31T22:21:34Z","timestamp":1490998894000},"page":"255-261","source":"Crossref","is-referenced-by-count":3,"title":["Occult Hepatitis B Virus Infection in Hyperlipidemia Patients"],"prefix":"10.1620","volume":"241","author":[{"given":"Liu","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Transfusion Medicine, School of Laboratory Medicine and Biotechnology, Southern Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine, School of Laboratory Medicine and Biotechnology, Southern Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenmin","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine, School of Laboratory Medicine and Biotechnology, Southern Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine, School of Laboratory Medicine and Biotechnology, Southern Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinfeng","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine, School of Laboratory Medicine and Biotechnology, Southern Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruiwen","family":"Long","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine, School of Laboratory Medicine and Biotechnology, Southern Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongshui","family":"Fu","sequence":"additional","affiliation":[{"name":"Guangzhou Blood Center, Guangzhou, Guangdong Province"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Pierre","family":"Allain","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine, School of Laboratory Medicine and Biotechnology, Southern Medical University"},{"name":"Department of Hematology, University of Cambridge"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengyao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine, School of Laboratory Medicine and Biotechnology, Southern Medical University"},{"name":"School of Public Health and Tropical Medicine, Southern Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"622","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Allain, J.P. &amp; Candotti, D.; ISBT HBV Safety Collaborative Group (2012) Hepatitis B virus in transfusion medicine: still a problem? <i>Biologicals<\/i>, 40, 180-186.","DOI":"10.1016\/j.biologicals.2011.09.014"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Allain, J.P. &amp; Cox, L. (2011) Challenges in hepatitis B detection among blood donors. <i>Curr. Opin. Hematol.<\/i>, 18, 461-466.","DOI":"10.1097\/MOH.0b013e32834bac10"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Amponsah-Dacosta, E., Lebelo, R.L., Rakgole, J.N., Selabe, S.G., Gededzha, M.P., Mayaphi, S.H., Powell, E.A., Blackard, J.T. &amp; Mphahlele, M.J. (2015) Hepatitis B virus infection in post-vaccination South Africa: occult HBV infection and circulating surface gene variants. <i>J. Clin. Virol.<\/i>, 63, 12-17.","DOI":"10.1016\/j.jcv.2014.11.032"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Askgaard, G., Gr\u00f8nb\u00e6k, M., Kj\u00e6r, M.S., Tj\u00f8nneland, A. &amp; Tolstrup, J.S. (2015) Alcohol drinking pattern and risk of alcoholic liver cirrhosis: a prospective cohort study. <i>J. Hepatol.<\/i>, 62, 1061-1067.","DOI":"10.1016\/j.jhep.2014.12.005"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Barr, T., Helms, C., Grant, K. &amp; Messaoudi, I. (2016) Opposing effects of alcohol on the immune system. <i>Prog. Neuropsychopharmacol. Biol. Psychiatry<\/i>, 65, 242-251.","DOI":"10.1016\/j.pnpbp.2015.09.001"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Bass, K.M., Newschaffer, C.J., Klag, M.J. &amp; Bush, T.L. (1993) Plasma lipoprotein levels as predictors of cardiovascular death in women. <i>Arch. Intern. Med.<\/i>, 153, 2209-2216.","DOI":"10.1001\/archinte.1993.00410190045006"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Bhargava, A., Khan, S., Panwar, H., Pathak, N., Punde, R.P., Varshney, S. &amp; Mishra, P.K. (2010) Occult hepatitis B virus infection with low viremia induces DNA damage, apoptosis and oxidative stress in peripheral blood lymphocytes. <i>Virus Res.<\/i>, 153, 143-150.","DOI":"10.1016\/j.virusres.2010.07.023"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Bittner, V. (2005) Perspectives on dyslipidemia and coronary heart disease in women. <i>J. Am. Coll. Cardiol.<\/i>, 46, 1628-1635.","DOI":"10.1016\/j.jacc.2005.05.089"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Chamni, N., Louisirirotchanakul, S., Oota, S., Sakuldamrongpanish, T., Saldanha, J., Chongkolwatana, V. &amp; Phikulsod, S. (2014) Genetic characterization and genotyping of hepatitis B virus (HBV) isolates from donors with an occult HBV infection. <i>Vox Sang.<\/i>, 107, 324-332.","DOI":"10.1111\/vox.12178"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Chandra, P.K., Biswas, A., Datta, S., Banerjee, A., Panigrahi, R., Chakrabarti, S., De, B.K. &amp; Chakravarty, R. (2009) Subgenotypes of hepatitis B virus genotype D (D1, D2, D3 and D5) in India: differential pattern of mutations, liver injury and occult HBV infection. <i>J. Viral Hepat.<\/i>, 16, 749-756.","DOI":"10.1111\/j.1365-2893.2009.01129.x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Chen, J.Y., Wang, J.H., Lin, C.Y., Chen, P.F., Tseng, P.L., Chen, C.H., Chang, K.C., Tsai, L.S., Chen, S.C. &amp; Lu, S.N. (2010) Lower prevalence of hypercholesterolemia and hyperglyceridemia found in subjects with seropositivity for both hepatitis B and C strains independently. <i>J. Gastroenterol. Hepatol.<\/i>, 25, 1763-1768.","DOI":"10.1111\/j.1440-1746.2010.06300.x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Chen, S.J., Zhao, Y.X., Fang, Y., Xu, W.Z., Ma, Y.X., Song, Z.W., Teng, X. &amp; Gu, H.X. (2012) Viral deletions among healthy young Chinese adults with occult hepatitis B virus infection. <i>Virus Res.<\/i>, 163, 197-201.","DOI":"10.1016\/j.virusres.2011.09.029"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Chung, T.H., Kim, M.C. &amp; Kim, C.S. (2014) Association between Hepatitis B Surface Antigen Seropositivity and Metabolic Syndrome. <i>Korean J. Fam. Med.<\/i>, 35, 81-89.","DOI":"10.4082\/kjfm.2014.35.2.81"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Demir, M., Serin, E., G\u00f6kt\u00fcrk, S., Ozturk, N.A., Kulaksizoglu, S. &amp; Ylmaz, U. (2008) The prevalence of occult hepatitis B virus infection in type 2 diabetes mellitus patients. <i>Eur. J. Gastroenterol. Hepatol.<\/i>, 20, 668-673.","DOI":"10.1097\/MEG.0b013e3282f55e1e"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Estoppey, D., Paccaud, F., Vollenweider, P. &amp; Marques-Vidal, P. (2011) Trends in self-reported prevalence and management of hypertension, hypercholesterolemia and diabetes in Swiss adults, 1997-2007. <i>BMC Public Health<\/i>, 11, 114.","DOI":"10.1186\/1471-2458-11-114"},{"key":"16","doi-asserted-by":"crossref","unstructured":"European Association for the Study of Liver (2012) EASL clinical practical guidelines: management of alcoholic liver disease. <i>J. Hepatol.<\/i>, 57, 399-420.","DOI":"10.1016\/j.jhep.2012.04.004"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). <i>JAMA<\/i>, 285, 2486-2497.","DOI":"10.1001\/jama.285.19.2486"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Fang, Y., Teng, X., Xu, W.Z., Li, D., Zhao, H.W., Fu, L.J., Zhang, F.M. &amp; Gu, H.X. (2009) Molecular characterization and functional analysis of occult hepatitis B virus infection in Chinese patients infected with genotype C. <i>J. Med. Virol.<\/i>, 81, 826-835.","DOI":"10.1002\/jmv.21463"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Hashemi, S.J., Hajiani, E., Masjedizadeh, A., Makvandi, M., Shayesteh, A.A., Alavinejad, S.P., Kadkhodaei, A., Shahbazian, H., Jasemi, F. &amp; Karimi, M. (2015) Occult hepatitis B infection in patients with cryptogenic liver cirrhosis in southwest of Iran. <i>Jundishapur J. Microbiol.<\/i>, 8, e16873.","DOI":"10.5812\/jjm.16873"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Hassan, Z.K., Hafez, M.M., Mansor, T.M. &amp; Zekri, A.R. (2011) Occult HBV infection among Egyptian hepatocellular carcinoma patients. <i>Virol. J.<\/i>, 8, 90.","DOI":"10.1186\/1743-422X-8-90"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Hsu, C.S., Liu, C.H., Wang, C.C., Tseng, T.C., Liu, C.J., Chen, C.L., Chen, P.J., Chen, D.S. &amp; Kao, J.H. (2012) Impact of hepatitis B virus infection on metabolic profiles and modifying factors. <i>J. Viral Hepat.<\/i>, 19, e48-57.","DOI":"10.1111\/j.1365-2893.2011.01535.x"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Huang, C.Y., Lu, C.W., Liu, Y.L., Chiang, C.H., Lee, L.T. &amp; Huang, K.C. (2016) Relationship between chronic hepatitis B and metabolic syndrome: a structural equation modeling approach. <i>Obesity <\/i>(<i>Silver Spring<\/i>), 24, 483-489.","DOI":"10.1002\/oby.21333"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Inuzuka, T., Ueda, Y., Morimura, H., Fujii, Y., Umeda, M., Kou, T., Osaki, Y., Uemoto, S., Chiba, T. &amp; Marusawa, H. (2014) Reactivation from occult HBV carrier status is characterized by low genetic heterogeneity with the wild-type or G1896A variant prevalence. <i>J. Hepatol.<\/i>, 61, 492-501.","DOI":"10.1016\/j.jhep.2014.04.033"},{"key":"24","unstructured":"Itoh, S. &amp; Shimoji, K. (1986) Effects of alcohol on the liver in HBsAg carriers. <i>Am. J. Gastroenterol.<\/i>, 81, 779-782."},{"key":"25","doi-asserted-by":"crossref","unstructured":"Jan, C.F., Chen, C.J., Chiu, Y.H., Chen, L.S., Wu, H.M., Huang, C.C., Yen, M.F. &amp; Chen, T.H. (2006) A population-based study investigating the association between metabolic syndrome and hepatitis B\/C infection (Keelung Community-based Integrated Screening study No. 10). <i>Int. J. Obes. <\/i>(<i>Lond<\/i>), 30, 794-799.","DOI":"10.1038\/sj.ijo.0803204"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Kwak, M.S. &amp; Kim, Y.J. (2014) Occult hepatitis B virus infection. <i>World J. Hepatol.<\/i>, 6, 860-869.","DOI":"10.4254\/wjh.v6.i12.860"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Li-Ng, M., Tropp, S., Danoff, A. &amp; Bini, E.J. (2007) Association between chronic hepatitis B virus infection and diabetes among Asian Americans and Pacific Islanders. <i>Dig. Liver Dis.<\/i>, 39, 549-556.","DOI":"10.1016\/j.dld.2007.02.014"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Liu, P.T., Hwang, A.C. &amp; Chen, J.D. (2013) Combined effects of hepatitis B virus infection and elevated alanine aminotransferase levels on dyslipidemia. <i>Metabolism<\/i>, 62, 220-225.","DOI":"10.1016\/j.metabol.2012.07.022"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Martin, C.M., Welge, J.A., Shire, N.J., Shata, M.T., Sherman, K.E. &amp; Blackard, J.T. (2009) Cytokine expression during chronic versus occult hepatitis B virus infection in HIV co-infected individuals. <i>Cytokine<\/i>, 47, 194-198.","DOI":"10.1016\/j.cyto.2009.06.005"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Milias, G.A., Panagiotakos, D.B., Pitsavos, C., Xenaki, D., Panagopoulos, G. &amp; Stefanadis, C. (2006) Prevalence of self-reported hypercholesterolaemia and its relation to dietary habits in Greek adults; a national nutrition &amp; health survey. <i>Lipids Health Dis.<\/i>, 5, 5.","DOI":"10.1186\/1476-511X-5-5"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Muldoon, M.F., Marsland, A., Flory, J.D., Rabin, B.S., Whiteside, T.L. &amp; Manuck, S.B. (1997) Immune system differences in men with hypo- or hypercholesterolemia. <i>Clin. Immunol. Immunopathol.<\/i>, 84, 145-149.","DOI":"10.1006\/clin.1997.4382"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Pinarbasi, B., Onel, D., Cosan, F., Akyuz, F., Dirlik, N., Cakaloglu, Y., Badur, S., Besisik, F., Demir, K., Okten, A. &amp; Kaymakoglu, S. (2009) Prevalence and virological features of occult hepatitis B virus infection in female sex workers who work uncontrolled in Turkey. <i>Liver Int.<\/i>, 29, 227-230.","DOI":"10.1111\/j.1478-3231.2008.01809.x"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Primatesta, P. &amp; Poulter, N.R. (2006) Levels of dyslipidaemia and improvement in its management in England: results from the Health Survey for England 2003. <i>Clin. Endocrinol. <\/i>(<i>Oxf<\/i>), 64, 292-298.","DOI":"10.1111\/j.1365-2265.2006.02459.x"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Raimondo, G., Allain, J.P., Brunetto, M.R., Buendia, M.A., Chen, D.S., Colombo, M., Crax\u00ec, A., Donato, F., Ferrari, C., Gaeta, G.B., Gerlich, W.H., Levrero, M., Locarnini, S., Michalak, T., Mondelli, M.U., et al. (2008) Statements from the Taormina expert meeting on occult hepatitis B virus infection. <i>J. Hepatol.<\/i>, 49, 652-657.","DOI":"10.1016\/j.jhep.2008.07.014"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Raimondo, G., Caccamo, G., Filomia, R. &amp; Pollicino, T. (2013) Occult HBV infection. <i>Semin. Immunopathol.<\/i>, 35, 39-52.","DOI":"10.1007\/s00281-012-0327-7"},{"key":"36","doi-asserted-by":"crossref","unstructured":"Sa-Nguanmoo, P., Tangkijvanich, P., Tharmaphornpilas, P., Rasdjarmrearnsook, A.O., Plianpanich, S., Thawornsuk, N., Theamboonlers, A. &amp; Poovorawan, Y. (2012) Molecular analysis of hepatitis B virus associated with vaccine failure in infants and mothers: a case-control study in Thailand. <i>J. Med. Virol.<\/i>, 84, 1177-1185.","DOI":"10.1002\/jmv.23260"},{"key":"37","doi-asserted-by":"crossref","unstructured":"Smit, J.W. &amp; Diamant, M. (2004) Genetically defined hyperlipidemia. <i>Pharmacogenomics<\/i>, 5, 295-304.","DOI":"10.1517\/phgs.5.3.295.29835"},{"key":"38","doi-asserted-by":"crossref","unstructured":"Wong, V.W., Wong, G.L., Chu, W.C., Chim, A.M., Ong, A., Yeung, D.K., Yiu, K.K., Chu, S.H., Chan, H.Y., Woo, J., Chan, F.K. &amp; Chan, H.L. (2012) Hepatitis B virus infection and fatty liver in the general population. <i>J. Hepatol.<\/i>, 56, 533-540.","DOI":"10.1016\/j.jhep.2011.09.013"},{"key":"39","doi-asserted-by":"crossref","unstructured":"Yang, Z., Zhuang, L., Lu, Y., Xu, Q., Tang, B. &amp; Chen, X. (2016) Naturally occurring basal core promoter A1762T\/G1764A dual mutations increase the risk of HBV-related hepatocellular carcinoma: a meta-analysis. <i>Oncotarget<\/i>, 7, 12525-12536.","DOI":"10.18632\/oncotarget.7123"},{"key":"40","doi-asserted-by":"crossref","unstructured":"Yimnoi, P., Posuwan, N., Wanlapakorn, N., Tangkijvanich, P., Theamboonlers, A., Vongpunsawad, S. &amp; Poovorawan, Y. (2016) A molecular epidemiological study of the hepatitis B virus in Thailand after 22 years of universal immunization. <i>J. Med. Virol.<\/i>, 88, 664-673.","DOI":"10.1002\/jmv.24368"},{"key":"41","doi-asserted-by":"crossref","unstructured":"Zhang, M., Lu, Y., Liu, X., Zhang, X., Zhang, C., Gao, W. &amp; Tie, Y. (2016) Relationship between XspI site polymorphisms of LDL-R gene and serum IL-2 and IL-10 in patients with hypercholesterolemia. <i>J. Clin. Lab. Anal.<\/i>, 30, 1122-1127.","DOI":"10.1002\/jcla.21991"},{"key":"42","doi-asserted-by":"crossref","unstructured":"Zheng, X., Ye, X., Zhang, L., Wang, W., Shuai, L., Wang, A., Zeng, J., Candotti, D., Allain, J.P. &amp; Li, C. (2011) Characterization of occult hepatitis B virus infection from blood donors in China. <i>J. Clin. Microbiol.<\/i>, 49, 1730-1737.","DOI":"10.1128\/JCM.00145-11"}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/241\/4\/241_255\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T13:48:25Z","timestamp":1568987305000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/241\/4\/241_255\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.241.255","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"value":"0040-8727","type":"print"},{"value":"1349-3329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}